Fifth Third Bancorp Portfolio holdings
Fifth Third Bancorp is the holding company for Fifth Third Bank, whose odd name comes from the 1908 merger of Fifth National Bank and Third National Bank. Legend has it that the order was chosen over "Third Fifth" because, with prohibition ideas gaining ground, that could have sounded like three fifths of alcohol. The bank traces its roots to the Bank of the Ohio Valley, started by William W. Scarborough in 1858 and taken over by Third National Bank in 1871. Fifth Third bought MB Financial in 2018 and merged with Comerica Bank in February 2026.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$12.5M |
| 2 |
Intel
INTC
|
+$11.5M |
| 3 |
AGN
Allergan plc
AGN
|
+$11.4M |
| 4 |
Cisco
CSCO
|
+$11.1M |
| 5 |
Packaging Corp of America
PKG
|
+$10.7M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
UBS E-TRACS Alerian MLP Infrastructure ETN
MLPI
|
+$70.4M |
| 2 |
Viatris
VTRS
|
+$14M |
| 3 |
LO
LORILLARD INC COM STK
LO
|
+$13.1M |
| 4 |
iShares Russell 2000 ETF
IWM
|
+$12.6M |
| 5 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$11.5M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 25.61% |
| 2 | Healthcare | 12.03% |
| 3 | Consumer Staples | 10.96% |
| 4 | Technology | 9.93% |
| 5 | Financials | 9.45% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
1
Procter & Gamble
PG
$391B
| $606M | 5.53% |
7,242,138
-21,008
| -0.3% | -$1.72M |
2013 Q2
5 quarters
|
|
2
Vanguard Real Estate ETF
VNQ
$38.9B
| $308M | 2.8% |
4,280,485
-13,871
| -0.3% | -$1.05M |
2013 Q2
5 quarters
|
|
3
ExxonMobil
XOM
$672B
| $247M | 2.25% |
2,630,214
+23,245
| +0.9% | +$2.32M |
2013 Q2
5 quarters
|
|
4
Apple
AAPL
$5.07T
| $223M | 2.03% |
8,851,012
-14,800
| -0.2% | -$363K |
2013 Q2
5 quarters
|
|
|
5
DELISTED
UBS E-TRACS Alerian MLP Infrastructure ETN
MLPI
| $213M | 1.94% |
4,663,295
-1,581,480
| -25% | -$70.4M |
2013 Q2
5 quarters
|
|
6
Johnson & Johnson
JNJ
$675B
| $178M | 1.63% |
1,673,478
-3,467
| -0.2% | -$360K |
2013 Q2
5 quarters
|
|
7
iShares MSCI EAFE ETF
EFA
$77.4B
| $157M | 1.43% |
2,441,058
-96,525
| -4% | -$6.44M |
2013 Q2
5 quarters
|
|
|
8
Gilead Sciences
GILD
$211B
| $149M | 1.36% |
1,401,248
+127,208
| +10% | +$12.5M |
2013 Q2
5 quarters
|
|
9
GE Aerospace
GE
$350B
| $143M | 1.3% |
1,161,217
-38,602
| -3% | -$4.81M |
2013 Q2
5 quarters
|
|
10
iShares Core S&P 500 ETF
IVV
$869B
| $128M | 1.17% |
647,071
+5,471
| +0.9% | +$1.09M |
2013 Q2
5 quarters
|
|
11
iShares Russell Mid-Cap ETF
IWR
$58.3B
| $123M | 1.12% |
3,118,920
-77,000
| -2% | -$3.1M |
2013 Q2
5 quarters
|
|
12
JPMorgan Chase
JPM
$910B
| $120M | 1.09% |
1,993,295
-34,745
| -2% | -$2.03M |
2013 Q2
5 quarters
|
|
13
Chevron
CVX
$413B
| $119M | 1.08% |
993,209
-8,693
| -0.9% | -$1.11M |
2013 Q2
5 quarters
|
|
14
Wells Fargo
WFC
$258B
| $114M | 1.04% |
2,197,746
-22,778
| -1% | -$1.17M |
2013 Q2
5 quarters
|
|
15
Microsoft
MSFT
$3.97T
| $112M | 1.02% |
2,407,906
+65,475
| +3% | +$2.92M |
2013 Q2
5 quarters
|
|
|
16
Intel
INTC
$308B
| $108M | 0.99% |
3,113,091
+340,158
| +12% | +$11.5M |
2013 Q2
5 quarters
|
|
17
SLB Ltd
SLB
$73.9B
| $108M | 0.98% |
1,059,388
+43,151
| +4% | +$4.7M |
2013 Q2
5 quarters
|
|
18
State Street SPDR S&P 500 ETF Trust
SPY
$795B
| $106M | 0.97% |
538,913
+4,161
| +0.8% | +$823K |
2013 Q2
5 quarters
|
|
19
iShares Core S&P Mid-Cap ETF
IJH
$125B
| $98.2M | 0.89% |
3,589,425
-81,645
| -2% | -$2.3M |
2013 Q2
5 quarters
|
|
|
20
iShares Russell 2000 ETF
IWM
$77.8B
| $96.5M | 0.88% |
882,704
-110,553
| -11% | -$12.6M |
2013 Q2
5 quarters
|
|
21
IBM
IBM
$230B
| $94.8M | 0.86% |
522,092
-3,449
| -0.7% | -$628K |
2013 Q2
5 quarters
|
|
22
RTX Corp
RTX
$271B
| $93.8M | 0.85% |
1,410,821
-13,271
| -0.9% | -$910K |
2013 Q2
5 quarters
|
|
23
US Bancorp
USB
$94.7B
| $92.8M | 0.85% |
2,217,606
-48,292
| -2% | -$2.04M |
2013 Q2
5 quarters
|
|
24
Pfizer
PFE
$167B
| $92.5M | 0.84% |
3,296,209
-131,151
| -4% | -$3.68M |
2013 Q2
5 quarters
|
|
25
PepsiCo
PEP
$195B
| $91.3M | 0.83% |
980,787
+31,822
| +3% | +$2.91M |
2013 Q2
5 quarters
|
|
Similar funds
Fifth Third Bancorp's Q3 2014 Portfolio in Review
As of Q3 2014, Fifth Third Bancorp held 2,610 positions worth $11B, down 0.62% from $11B the previous quarter. Its ten largest holdings account for 21% of the portfolio.
Fifth Third Bancorp's Q3 2014 filing shows 173 new, 714 increased, 890 reduced and 226 closed positions. Its largest new stake was Signet Jewelers: 27,614 shares worth $3.15M. The largest sale was UBS E-TRACS Alerian MLP Infrastructure ETN, an estimated $70.4M.
By sector, the portfolio is most concentrated in Miscellaneous at 26% of assets, down from 27% a quarter earlier, followed by Healthcare and Consumer Staples.
- Fifth Third Bancorp's largest Q3 2014 buy was Signet Jewelers: 27,614 shares worth $3.15M.
- Fifth Third Bancorp added most to Gilead Sciences in Q3 2014, an estimated $12.5M increase.
- Fifth Third Bancorp's biggest Q3 2014 reduction was UBS E-TRACS Alerian MLP Infrastructure ETN, cutting an estimated $70.4M.
- Fifth Third Bancorp fully exited HILLSHIRE BRANDS CO in Q3 2014, selling an estimated $1.17M.
- Fifth Third Bancorp's ten largest holdings make up 21% of its $11B portfolio in Q3 2014.
- Fifth Third Bancorp opened 173 new positions and closed 226 in Q3 2014.
- Fifth Third Bancorp's portfolio value fell 0.62% quarter-over-quarter to $11B.
Based on Fifth Third Bancorp's 13F filing for Q3 2014, filed 17 Nov 2014.